nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.0797	0.155	CbGeAlD
Tramadol—Venlafaxine—SLC6A3—Gilles de la Tourette syndrome	0.0511	1	CrCbGaD
Tramadol—GRIN3A—nervous system—Gilles de la Tourette syndrome	0.0287	0.0557	CbGeAlD
Tramadol—GRIN3A—central nervous system—Gilles de la Tourette syndrome	0.0276	0.0536	CbGeAlD
Tramadol—GRIN3A—brain—Gilles de la Tourette syndrome	0.0219	0.0426	CbGeAlD
Tramadol—OPRD1—nervous system—Gilles de la Tourette syndrome	0.0202	0.0392	CbGeAlD
Tramadol—OPRD1—central nervous system—Gilles de la Tourette syndrome	0.0194	0.0378	CbGeAlD
Tramadol—OPRK1—nervous system—Gilles de la Tourette syndrome	0.0194	0.0376	CbGeAlD
Tramadol—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.0186	0.0362	CbGeAlD
Tramadol—OPRM1—midbrain—Gilles de la Tourette syndrome	0.0168	0.0326	CbGeAlD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0167	0.0385	CbGpPWpGaD
Tramadol—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—Gilles de la Tourette syndrome	0.0161	0.0371	CbGpPWpGaD
Tramadol—OPRD1—brain—Gilles de la Tourette syndrome	0.0154	0.03	CbGeAlD
Tramadol—OPRK1—brain—Gilles de la Tourette syndrome	0.0148	0.0288	CbGeAlD
Tramadol—HTR2C—midbrain—Gilles de la Tourette syndrome	0.0147	0.0286	CbGeAlD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0147	0.0338	CbGpPWpGaD
Tramadol—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.0139	0.0271	CbGeAlD
Tramadol—OPRM1—nervous system—Gilles de la Tourette syndrome	0.0138	0.0268	CbGeAlD
Tramadol—OPRM1—central nervous system—Gilles de la Tourette syndrome	0.0133	0.0258	CbGeAlD
Tramadol—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.0129	0.0297	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0124	0.0285	CbGpPWpGaD
Tramadol—SLC6A4—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0124	0.0284	CbGpPWpGaD
Tramadol—HTR2C—nervous system—Gilles de la Tourette syndrome	0.0121	0.0235	CbGeAlD
Tramadol—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.0116	0.0226	CbGeAlD
Tramadol—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.0115	0.0223	CbGeAlD
Tramadol—SLC6A2—Amine compound SLC transporters—SLC6A3—Gilles de la Tourette syndrome	0.0112	0.0258	CbGpPWpGaD
Tramadol—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.011	0.0214	CbGeAlD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0106	0.0245	CbGpPWpGaD
Tramadol—SLC6A2—Monoamine Transport—SLC6A3—Gilles de la Tourette syndrome	0.0106	0.0245	CbGpPWpGaD
Tramadol—OPRM1—brain—Gilles de la Tourette syndrome	0.0105	0.0205	CbGeAlD
Tramadol—CHRM3—nervous system—Gilles de la Tourette syndrome	0.0102	0.0198	CbGeAlD
Tramadol—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.0101	0.0196	CbGeAlD
Tramadol—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00983	0.0191	CbGeAlD
Tramadol—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.00971	0.0189	CbGeAlD
Tramadol—HTR2C—brain—Gilles de la Tourette syndrome	0.00923	0.0179	CbGeAlD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00916	0.0211	CbGpPWpGaD
Tramadol—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00908	0.0209	CbGpPWpGaD
Tramadol—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00881	0.0203	CbGpPWpGaD
Tramadol—SLC6A4—brain—Gilles de la Tourette syndrome	0.00875	0.017	CbGeAlD
Tramadol—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00858	0.0198	CbGpPWpGaD
Tramadol—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00821	0.0189	CbGpPWpGaD
Tramadol—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00782	0.018	CbGpPWpGaD
Tramadol—CHRM3—brain—Gilles de la Tourette syndrome	0.0078	0.0152	CbGeAlD
Tramadol—SLC6A2—brain—Gilles de la Tourette syndrome	0.00771	0.015	CbGeAlD
Tramadol—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00763	0.0176	CbGpPWpGaD
Tramadol—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00759	0.0175	CbGpPWpGaD
Tramadol—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.00743	0.0144	CbGeAlD
Tramadol—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00741	0.0171	CbGpPWpGaD
Tramadol—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.00715	0.0139	CbGeAlD
Tramadol—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00707	0.0163	CbGpPWpGaD
Tramadol—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0069	0.0159	CbGpPWpGaD
Tramadol—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00657	0.0151	CbGpPWpGaD
Tramadol—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00638	0.0147	CbGpPWpGaD
Tramadol—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00594	0.0137	CbGpPWpGaD
Tramadol—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00575	0.0132	CbGpPWpGaD
Tramadol—CYP2B6—brain—Gilles de la Tourette syndrome	0.00568	0.011	CbGeAlD
Tramadol—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.00561	0.0109	CbGeAlD
Tramadol—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00552	0.0107	CbGeAlD
Tramadol—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.0054	0.0105	CbGeAlD
Tramadol—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00532	0.0103	CbGeAlD
Tramadol—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00495	0.0114	CbGpPWpGaD
Tramadol—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00483	0.0111	CbGpPWpGaD
Tramadol—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Gilles de la Tourette syndrome	0.00437	0.0101	CbGpPWpGaD
Tramadol—CYP2D6—brain—Gilles de la Tourette syndrome	0.00422	0.0082	CbGeAlD
Tramadol—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00416	0.00958	CbGpPWpGaD
Tramadol—SLC6A4—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00367	0.00845	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00347	0.00799	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00337	0.00776	CbGpPWpGaD
Tramadol—SLC6A2—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.00315	0.00726	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00309	0.00711	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.003	0.0069	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00297	0.00683	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00288	0.00663	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00279	0.00643	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00275	0.00634	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00268	0.00618	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00267	0.00615	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0026	0.00599	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00253	0.00581	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00249	0.00573	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00241	0.00556	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00239	0.00551	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00236	0.00543	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00235	0.00542	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00234	0.0054	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00229	0.00527	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0022	0.00506	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0022	0.00506	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00218	0.00503	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00213	0.00491	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00213	0.00491	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00207	0.00476	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00204	0.0047	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00201	0.00462	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00199	0.00458	CbGpPWpGaD
Tramadol—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00199	0.00458	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00198	0.00456	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00187	0.00431	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00184	0.00425	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0018	0.00414	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00175	0.00403	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00175	0.00402	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00174	0.00401	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00174	0.00401	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0017	0.00392	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0017	0.00391	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00162	0.00374	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00158	0.00365	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00158	0.00364	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00157	0.00363	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00153	0.00352	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00153	0.00352	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00151	0.00347	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0015	0.00346	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00149	0.00344	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00146	0.00337	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00146	0.00335	CbGpPWpGaD
Tramadol—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00144	0.00331	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00142	0.00328	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00136	0.00314	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00136	0.00313	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00133	0.00306	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00131	0.00302	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00129	0.00298	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00129	0.00298	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00129	0.00298	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00128	0.00296	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00125	0.00289	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00124	0.00285	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0012	0.00277	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00117	0.00269	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00114	0.00263	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00114	0.00262	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00255	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00111	0.00255	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00255	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00255	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00103	0.00238	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00101	0.00234	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00101	0.00233	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000998	0.0023	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000985	0.00227	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000984	0.00227	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000955	0.0022	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000955	0.0022	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000951	0.00219	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.000944	0.00217	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000922	0.00212	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000918	0.00211	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000895	0.00206	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00089	0.00205	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00089	0.00205	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000864	0.00199	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000843	0.00194	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000834	0.00192	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000819	0.00188	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000812	0.00187	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000808	0.00186	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000805	0.00185	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000785	0.00181	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000752	0.00173	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000731	0.00168	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00073	0.00168	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000724	0.00167	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000683	0.00157	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00068	0.00157	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000663	0.00153	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000646	0.00149	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000643	0.00148	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000627	0.00144	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000623	0.00144	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000618	0.00142	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000587	0.00135	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000584	0.00134	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000584	0.00134	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000569	0.00131	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000564	0.0013	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000564	0.0013	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000556	0.00128	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000544	0.00125	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00054	0.00124	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00053	0.00122	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000529	0.00122	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000512	0.00118	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000505	0.00116	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000503	0.00116	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000492	0.00113	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00049	0.00113	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000477	0.0011	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000476	0.0011	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000463	0.00107	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000457	0.00105	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000433	0.000996	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000432	0.000994	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000409	0.000942	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000404	0.000929	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000392	0.000902	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000372	0.000855	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	0.000369	0.000849	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000365	0.00084	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000352	0.000811	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000346	0.000798	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000345	0.000794	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000336	0.000775	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00032	0.000737	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000313	0.000722	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000302	0.000696	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000298	0.000687	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00029	0.000667	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00027	0.000621	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000256	0.000588	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000219	0.000505	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000189	0.000435	CbGpPWpGaD
